Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
Go back to Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat| (NASDAQ: CERT) | Delayed: 5.34 -0.2 (3.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.54 | 52 Week High | $ | |||
| Open | $5.48 | 52 Week Low | $ | |||
| Day High | $5.79 | P/E | N/A | |||
| Day Low | $5.31 | EPS | $ | |||
| Volume | 4,303,246 | |||||
